Limitations, agreements, and source contact

Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma · Source last updated 2018-09-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

limitations And Caveats

description

slow accrual, preliminary analysis suggesting futility and combining of consortia, trial closed early

point Of Contact

email

jfisher@jhmi.edu

organization

North American Brain Tumor Consortium

phone

410-955-3657

title

Lauren Abrey, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice